These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 23839177)

  • 21. Laboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis.
    Lee YH; Scharnitz TP; Muscat J; Chen A; Gupta-Elera G; Kirby JS
    JAMA Dermatol; 2016 Jan; 152(1):35-44. PubMed ID: 26630323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isotretinoin: stroke and myocardial infarction?
    Prescrire Int; 2007 Jun; 16(89):113. PubMed ID: 17590908
    [No Abstract]   [Full Text] [Related]  

  • 23. Terminal hematuria associated with oral isotretinoin treatment in a patient with acne vulgaris.
    Sarifakioglu E; Yilmaz AE; Erpolat S
    Pediatr Dermatol; 2012; 29(5):668-9. PubMed ID: 22067016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe acne infantum successfully treated with isotretinoin.
    Torrelo A; Pastor MA; Zambrano A
    Pediatr Dermatol; 2005; 22(4):357-9. PubMed ID: 16060877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infantile acne treated with oral isotretinoin.
    Miller IM; Echeverría B; Torrelo A; Jemec GB
    Pediatr Dermatol; 2013; 30(5):513-8. PubMed ID: 23278140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin.
    Baykal Selçuk L; Aksu Arıca D; Baykal Şahin H; Yaylı S; Bahadır S
    Cutan Ocul Toxicol; 2017 Jun; 36(2):176-179. PubMed ID: 27764978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isotretinoin systemic therapy and the shadow cast upon dermatology's downtrodden hero.
    Lowenstein EB; Lowenstein EJ
    Clin Dermatol; 2011; 29(6):652-61. PubMed ID: 22014987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness Of Oral Omega 3 In Reducing Mucocutaneous Side Effects Of Oral Isotretinoin In Patients With Acne Vulgaris.
    Zainab Z; Malik NA; Obaid S; Malik S; Aftab K; Mumtaz M; Pervez A; Syed Z
    J Ayub Med Coll Abbottabad; 2021; 33(1):60-63. PubMed ID: 33774956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Observational retrospective study evaluating the effects of oral isotretinoin in keloids and hypertrophic scars.
    Guadanhim LR; Gonçalves RG; Bagatin E
    Int J Dermatol; 2016 Nov; 55(11):1255-1258. PubMed ID: 27419807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral isotretinoin for acne, adjusting treatment according to patient's response.
    Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
    J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Night blindness following low-dose isotretinoin.
    Halpagi P; Grigg J; Klistorner A; Damian DL
    J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):893-4. PubMed ID: 18031494
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute acne flare following isotretinoin administration: potential protective role of low starting dose.
    Borghi A; Mantovani L; Minghetti S; Virgili A; Bettoli V
    Dermatology; 2009; 218(2):178-80. PubMed ID: 19060474
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of isotretinoin in acne therapy: why not as first-line therapy? facts and controversies.
    Rigopoulos D; Larios G; Katsambas AD
    Clin Dermatol; 2010; 28(1):24-30. PubMed ID: 20082946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dermabrasion for acne scars during treatment with oral isotretinoin.
    Bagatin E; dos Santos Guadanhim LR; Yarak S; Kamamoto CS; de Almeida FA
    Dermatol Surg; 2010 Apr; 36(4):483-9. PubMed ID: 20180836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ABSORICA (isotretinoin): a new form.
    Scheinfeld N
    Skinmed; 2013; 11(2):117-9. PubMed ID: 23745231
    [No Abstract]   [Full Text] [Related]  

  • 36. Isotretinoin dosing: past, present, and future trends.
    Hirsch RJ; Shalita AR
    Semin Cutan Med Surg; 2001 Sep; 20(3):162-5. PubMed ID: 11594671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On isotretinoin dosing, adverse effects, and efficacy.
    Berk DR
    Australas J Dermatol; 2011 May; 52(2):147-8; author reply 148. PubMed ID: 21605103
    [No Abstract]   [Full Text] [Related]  

  • 38. Isotretinoin (roaccutane) usage--a South African consensus guideline. National Dermatology Working Group.
    S Afr Med J; 1997 Oct; 87(10 Pt 2):1410-3. PubMed ID: 11496385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us?
    Rademaker M
    Australas J Dermatol; 2013 Aug; 54(3):157-62. PubMed ID: 23013115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
    Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
    J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.